| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $417.0M | -0.0% |
| Cost of Revenue | $90.7M | -0.9% |
| Gross Profit | $326.3M | +0.2% |
| R&D Expense | $109.4M | +2.1% |
| SG&A Expense | $76.6M | +55.7% |
| Operating Income | $18.7M | +43.2% |
| Pre-tax Income | $33.7M | +35.3% |
| Income Tax | $6.7M | +132.9% |
| Net Income | $27.0M | +22.6% |
| EPS (Basic) | $0.16 | +23.1% |
| EPS (Diluted) | $0.16 | +23.1% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $325.3M | +7.9% |
| Accounts Receivable | $24.6M | -7.4% |
| Current Assets | $374.7M | +6.6% |
| Total Assets | $642.8M | +3.2% |
| Current Liabilities | $222.4M | -2.0% |
| Stockholders' Equity | $408.8M | +6.9% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $56.9M | +50.5% |
| Capital Expenditures | $222K | +105.6% |
| Investing Cash Flow | -$222K | -141.8% |
| Financing Cash Flow | -$32.2M | -175.1% |
| Free Cash Flow | $56.6M | +50.3% |